Published in Brain Pathol on September 16, 2011
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival. Oncotarget (2013) 0.99
Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment. Cancer J (2012) 0.94
Therapeutic potential and challenges of natural killer cells in treatment of solid tumors. Front Immunol (2015) 0.93
Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance. Cell Death Dis (2014) 0.93
Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures. Neuro Oncol (2012) 0.91
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. J Immunol (2015) 0.91
Immune responses to human cancer stem-like cells/cancer-initiating cells. Cancer Sci (2015) 0.84
The PD-1/B7-H1 pathway modulates the natural killer cells versus mouse glioma stem cells. PLoS One (2015) 0.84
Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity. Oncoimmunology (2012) 0.83
Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours. J Neurooncol (2013) 0.81
NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival. J Immunol (2014) 0.81
Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells. J Cancer (2015) 0.79
Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma. PLoS One (2014) 0.78
An overview of therapeutic approaches to brain tumor stem cells. Med J Islam Repub Iran (2012) 0.76
Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes. PLoS One (2016) 0.76
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain. BMC Cancer (2015) 0.76
Positive and negative regulation by NK cells in cancer. Crit Rev Oncog (2014) 0.76
Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy. Cytotechnology (2014) 0.76
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing. PLoS One (2016) 0.75
Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand. Cancer Cell Int (2017) 0.75
Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood (2008) 3.71
Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci (2004) 2.96
DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics (2010) 2.32
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst (2002) 2.25
Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone (2006) 2.23
Phenotypic expression in detected C282Y homozygous women depends on body mass index. J Hepatol (2005) 2.15
Simultaneous analysis of distinct Omics data sets with integration of biological knowledge: Multiple Factor Analysis approach. BMC Genomics (2009) 1.68
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods. J Neurooncol (2009) 1.64
Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy. J Neurooncol (2006) 1.45
Orchestrated transcription of biological processes in the marine picoeukaryote Ostreococcus exposed to light/dark cycles. BMC Genomics (2010) 1.42
CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart. Leuk Res (2009) 1.40
Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression. Genes Chromosomes Cancer (2009) 1.30
A transversal approach to predict gene product networks from ontology-based similarity. BMC Bioinformatics (2007) 1.29
Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int J Cancer (2008) 1.22
Intracranial epidural hematoma in newborn infants: clinical study of 15 cases. Neurosurgery (2005) 1.22
Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation. Eur J Med Genet (2010) 1.21
Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma. Cancer Res (2009) 1.20
Light-dependent regulation of cell division in Ostreococcus: evidence for a major transcriptional input. Plant Physiol (2007) 1.17
Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people. Br J Haematol (2002) 1.10
Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg (2009) 1.10
Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients. Clin Cancer Res (2006) 1.09
Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach. Proteome Sci (2011) 1.08
Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance. Am J Hum Genet (2007) 1.07
Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol (2010) 1.05
Multicentric pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1. Case report and review of the literature. J Neurosurg (2005) 1.02
Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French series. Eur J Med Genet (2009) 1.02
Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions. J Neuroimmunol (2010) 1.01
A 4-gene signature associated with clinical outcome in high-grade gliomas. Clin Cancer Res (2011) 0.99
Array-CGH analysis indicates a high prevalence of genomic rearrangements in holoprosencephaly: an updated map of candidate loci. Hum Mutat (2009) 0.99
Activation of RhoB by hypoxia controls hypoxia-inducible factor-1alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells. Cancer Res (2006) 0.99
Combining evidence, biomedical literature and statistical dependence: new insights for functional annotation of gene sets. BMC Bioinformatics (2006) 0.98
Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons. Bone (2006) 0.98
Spinal epidural hematoma: not always an obvious diagnosis. Eur J Emerg Med (2012) 0.98
Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA). Breast Cancer Res Treat (2011) 0.97
Microarray analysis of differential gene expression in the liver of lean and fat chickens. Gene (2006) 0.96
Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia. BMC Genomics (2007) 0.95
SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas. PLoS One (2012) 0.94
NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis. Eur J Gastroenterol Hepatol (2004) 0.93
Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures. Neuro Oncol (2012) 0.91
Capillary haemangioma arising from the anterior choroidal artery. Childs Nerv Syst (2005) 0.91
Isolation of a new cell population in the glioblastoma microenvironment. J Neurooncol (2011) 0.88
Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study. World J Gastroenterol (2009) 0.88
Intradural extramedullary spinal inflammatory myofibroblastic tumor: case report and literature review. Eur Spine J (2011) 0.88
Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients. J Neurooncol (2014) 0.88
Olfactory ensheathing cell tumour: case report and literature review. J Neurooncol (2010) 0.88
Immune genes are associated with human glioblastoma pathology and patient survival. BMC Med Genomics (2012) 0.87
Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients. Thromb Haemost (2003) 0.87
Transcriptome variations in human CaCo-2 cells: a model for enterocyte differentiation and its link to iron absorption. Genomics (2004) 0.86
Increased expression of a COOH-truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells. Int J Cancer (2002) 0.86
Inhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts. Oncogene (2003) 0.86
5q12.1 deletion: delineation of a phenotype including mental retardation and ocular defects. Am J Med Genet A (2011) 0.86
A method exploiting syntactic patterns and the UMLS semantics for aligning biomedical ontologies: the case of OBO disease ontologies. Int J Med Inform (2007) 0.85
Mechanisms of immunomodulation in human glioblastoma. Immunotherapy (2011) 0.84
A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study. Blood Cells Mol Dis (2009) 0.83
Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts. Int J Radiat Oncol Biol Phys (2004) 0.83
Grading glioma tumors using OWL-DL and NCI Thesaurus. AMIA Annu Symp Proc (2007) 0.83
Integrating biological pathways in disease ontologies. Stud Health Technol Inform (2007) 0.83
Phase I study of topotecan in combination with concurrent radiotherapy in adults with glioblastoma. J Neurooncol (2003) 0.82
Diagnosis-related pitfall of a lateral sacral cyst. Case report. J Neurosurg Spine (2005) 0.82
Proteomic analysis of glioblastomas: what is the best brain control sample? J Proteomics (2013) 0.82
Aligning biomedical ontologies using lexical methods and the UMLS: the case of disease ontologies. Stud Health Technol Inform (2006) 0.82
Radiation-induced mitotic cell death and glioblastoma radioresistance: a new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1 alpha and survivin in U87 cells. Eur J Cancer (2013) 0.81
In vivo identification of solar radiation-responsive gene network: role of the p38 stress-dependent kinase. PLoS One (2010) 0.81
Hearing loss attributable to a cerebellopontine-angle arachnoid cyst in a child. Pediatr Neurosurg (2009) 0.81
In vivo and ex vivo UV-induced analysis of pigmentation gene expressions. J Invest Dermatol (2006) 0.81
Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis. J Neurooncol (2015) 0.81
Contribution of procalcitonin to occult bacteraemia detection in children. Scand J Infect Dis (2007) 0.80
RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death. Oncogene (2002) 0.79
Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas. PLoS One (2013) 0.79
Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins. J Neurooncol (2014) 0.79
Prokineticin 1 induces CCL4, CXCL1 and CXCL8 in human monocytes but not in macrophages and dendritic cells. Eur Cytokine Netw (2008) 0.79